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I M M U N O H E M A T O L O G Y
 
Monoclonal antibody B2, a marker of neuroendocrine 
sympathoadrenal precursors, recognizes the Luke (LKE) antigen
 




 Blood group antigens are 
physiologically important differentiation markers in 
embryogenesis and development. Monoclonal antibody 
(MoAb) B2 recognizes a transient antigen expressed on 
late sympathoadrenal neuroendocrine precursors and 
early sympathetic neuroblasts. It has been suggested that 
MoAb B2 may recognize a globo-series glycosphingolipid 
(GSL) related to the P blood group family.
 
STUDY DESIGN AND METHODS:
 
 MoAb B2 and two 
anti-LKE MoAbs, MC813-70 and RM1, were screened 
against a panel of GSL standards and isolated red blood 
cell (RBC) GSLs by high-performance thin layer 
chromatography (HPTLC) immunostaining. The ability of 





cell carcinoma cell lines (A498, ACHN) were examined by 




 MoAbs B2, MC813-70, and RM1 all specifi-
cally recognized monosialogalactosylgloboside (MSGG) 
on HPTLC immunostaining. Only MoAb MC813-70 bound 
intact RBC by flow cytometry and hemagglutination. 
Differential staining was observed between the three 




 MoAb B2 recognizes MSGG or LKE anti-
gen, suggesting that LKE may play a role in neuroendo-
crine differentiation from neural crest cells. Although 
MoAb B2 is not suitable for RBC phenotyping, it may be 
a useful immunologic reagent for the identification of 
human embryonic stem cells and renal cell and embry-
onic carcinoma.
 
lycosphingolipids (GSLs) play a major role in
embryogenesis and cellular differentiation,
facilitating cell-cell recognition, adhesion, sig-








, arthro-family GSLs are integral in oogenesis,
preimplantation development, epidermal growth factor,





GSLs (Table 1) on embryonic stem cells and preimplanta-
tion embryos are implicated in cell-cell recognition,
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with the synthesis of additional, distinct globo-GSLs that





 Finally, the globo-ganglioside monosia-
logalactosylgloboside (MSGG) or LKE antigen has been
identified on afferent sensory neurons and sensory










 Like sympathetic neurons, adrenal chromaffin
cells arise from migrating neural crest cells and synthesize
catecholamines. Studies have shown that both sympa-
thetic neurons and adrenal chromaffin cells are products





latter differentiates rather late in development into either





Monoclonal antibody (MoAb) B2 is a transient marker
on late neuroendocrine precursors and early committed
neuroblasts. Although the epitope for MoAb B2 is
unknown, it has been suggested that B2 may recognize a
globo-series GSL. To test the latter, we screened MoAb B2
against a panel of GSL standards and isolated red blood
cell (RBC) GSLs. We also tested MoAb B2 as a possible






ACHN and A498 (ATCC HTB44) cells, two renal carcinoma
cell (RCC) lines, were purchased from the American
Tissue Type Collection (Manassas, VA). Cells were main-
tained in RPMI 1640 supplemented with 10 percent fetal




-glutamine, 1 mmol per L
sodium pyruvate, 1 mmol per L nonessential amino acids,




g/mL). Human RBCs from anony-
mous volunteer blood donors were obtained from the





 antigens per the manufacturer’s instruc-
tions (Gamma Biologics, Houston, TX). All tissue










































































 were purchased as hybridoma superna-
tants from the Developmental Studies Hybridoma Bank
 








































































































































































































































































































































































* Cer = ceramide; Gal = galactose; GalNAc = N-acetylgalactosamine; Glc = glucose; GlcNAc = N-acetylglucosamine; NeuAc = N-
acetylneuraminic acid.
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maintained by the Department of Biology at the Univer-
sity of Iowa (Iowa City, IA), under Contract N01-HD-2-
3144. MoAb RM1 (anti-MSGG, >50 mg/mL) was a gift of
A. Ito (Tohoku University School of Medicine, Sendai,
Japan).27 All antibodies were murine immunoglobulin M
(IgM) except MoAb MC813-70 (mouse immunoglobulin
G [IgG]). For hemagglutination experiments, 20 mL each
of B2 and RM1 supernatants was concentrated approxi-
mately 50-fold by filtration (Centricon Plus-20T, Millipore
Corp., Billerica, MA). Fluorescein isothiocyanate (FITC)-
labeled anti-mouse IgM, F(ab) anti-mouse IgG, and anti-
CD54 were purchased from Sigma Chemical Co. (St
Louis, MO). Biotinylated secondary antibodies against
mouse IgG and IgM, streptavidin-linked alkaline phos-
phatase, and alkaline phosphatase substrate (SK-5000)
were purchased from Vector Laboratories (Burlingame,
CA).
LKE phenotyping
RBC units were serologically typed for LKE antigen with
MoAb MC813-70 as described with modification.28,29
Briefly, washed RBC were digested with ficin as described
by Judd.30 For direct agglutination, one drop of ficin-
treated RBCs (3% in normal saline), two drops of MoAb
MC31-70 supernatant, and one drop of 22 percent bovine
serum albumin (BSA, Ortho, Raritan, NJ) were incubated
for 2 hours at 4∞C. Samples showing macroscopic agglu-
tination (≥1-4+) after immediate-spin centrifugation
(30 sec) were considered LKE–strong positive (LKE-S).
Samples that were negative at immediate-spin centrifu-
gation were retested by the indirect antiglobulin test with
MCT anti-mouse IgG gel columns (gift of H. Mylaski,
MCT, Pompano, FL). For the latter, 50 mL of RBCs (0.8%
suspension in MCT diluent) and 25 mL of MC813-70 were
incubated for 15 minutes at 37∞C, followed by 10 minutes
of centrifugation. Agglutination was scored per manufac-
turer’s instructions. Cells showing greater than 1+ agglu-
tination by gel were typed as LKE-weak (LKE-W).
Samples weak or negative (0-1+) by gel were typed as
LKE-negative (LKE-N). All LKE-W and LKE-N samples
were typed twice. Globo-null RBCs (p RBC, gift from J.
Judd, University of Michigan) were included as a negative
control.29
Flow cytometry
For ACHN and A498 cells, approximately 105 cells were
incubated with primary antibody and phosphate-buff-
ered saline (PBS)-1 percent BSA in a final volume of
100 mL for 30 minutes at 4∞C. Isotype controls included
MoAb MC480 (IgM) and anti-CD54 (IgG, Sigma). After
being washed, cells were incubated with either FITC-
labeled anti-mouse IgM (MoAbs B2, RM1) or FITC–
F(ab)–anti-mouse IgG (MoAb MC813-70). The use of
F(ab)–anti-mouse IgG was necessary to eliminate non-
specific binding by Fc receptors on renal epithelial cells.
After incubation (30 min, 4∞C), cells were washed thrice
and resuspended in 500 mL of PBS-1 percent paraformal-
dehyde. For RBCs, washed, ficin-treated RBCs (50 mL, 3%
suspension) were incubated with primary and secondary
antibodies as described above.28 Working dilutions for
anti-MSGG MoAbs were 1:100 (MC813-70) and 1:10 (B2,
RM1).
After fixation, cells were analyzed by one-color flow
cytometry (FACScan, Becton Dickinson, Franklin Lakes,
NJ) with computer software (Cell-Quest, Becton Dickin-
son). Cells were gated on forward and orthogonal scatter,
and the percentage of FITC-positive cells was determined.
All samples were stained in duplicate and recorded as the
mean percentage of positive cells and mean channel flu-
orescence intensity.
GSL isolation
The total neutral and ganglioside fraction from lympho-
cytes, neutrophils, monoblasts, kidney, and brain were
isolated as described previously.11,12 Gangliosides and
neutral GSLs from LKE-typed RBC were isolated by a mod-
ified procedure of Ledeen and Yu.31,32 Briefly, 30 mL of
LKE-typed, washed RBCs were sequentially extracted with
300 mL of chloroform-methanol (C-M) 1:1 and 1:2 (vol/
vol). After filtration, both lipid extracts were pooled, dried
in vacuo, and then resuspended in 0.5 mol per L methan-
olic sodium hydroxide. After incubation at 37∞C for 5
hours to saponify the bulk of alkali-labile phospholipids,33
samples were dried and dialyzed against distilled water
(MW cutoff, 3000; Spectra-Por, Houston, TX; 4∞C) to desalt
samples. After being dried, samples were resuspended in
100 mL C-M-water (30:60:8, vol/vol/vol) and applied to
a DEAE-A25 Sephadex column (10 mL bed volume [BV],
Sigma Chemical Co.). The column was washed with
200 mL of C-M-water 30:60:8 (vol/vol/vol) to remove neu-
tral lipids, including neutral GSLs. The column was then
stripped with 150 mL of C-M-0.8 mol per L sodium ace-
tate. The acidic lipid fraction was saponified (0.1 mol/L
NaOH, 2 hr, 37∞C) and dialyzed (MW cutoff 3000, Spectra-
Por) as before. After being dried, samples were resus-
pended in 35 mL of C-M 85:15 (vol/vol, 10 mL BV), applied
to a silica column (10 mL BV, 40 mm; J.T. Baker, Phillips-
burg, NJ), and washed with an additional 170 mL of C-M
85:15. Gangliosides were eluted with 130 mL of C-M 1:2
(vol/vol). Samples were dried and resuspended C-M 1:1
(10 mg/mL) for use.
High-performance thin-layer chromatography
High-performance thin-layer chromatography (HPTLC)
was performed as described.34 Total tissue ganglioside or
neutral fraction (50 mg/lane) and GSL controls (3-5 mg/
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lane) were applied to aluminum-backed HPTLC plates (E.
Merck, Darmstadt, Germany), developed in C-M-0.2
percent aqueous CaCl2 (55:45:10, vol/vol/vol). After being
air-dried, GSLs were visualized chemically with dipheny-
lamine reagent or stained by MoAbs. Individual GSLs were
identified based on their relative mobility (Rf) to standards
and immunoreactivity with MoAbs. GSL standards were
purchased from Sigma Chemical Co. or isolated previ-
ously in our laboratory.11,12 Staining intensity was deter-
mined by scanning densitometry of digitally scanned
images (Quantiscan, Biosoft, Ferguson, MO).
For immunostaining, HPTLC plates were dipped in
poly-(iso-butyl)methacrylate (PIBM) (0.2% in hexane) for
1 minute. Plates were dried and then blocked with Tris
buffer (50 mmol/L Tris-HCl, 150 mmol/L NaCl, 0.1%
azide, 1% BSA; pH 7.8) for 1 hour. Plates were subse-
quently overlayed with primary antibody for 1 hour,
washed with PBS, followed by biotinylated anti-mouse
immunoglobulin and streptavidin-linked alkaline phos-
phatase as described.11,12 Working dilutions for MoAbs
were 1:10 (MC813-70), 1:5 (MC631), and neat (B2, RM1).
Antibody binding was detected with alkaline phosphatase
in 100 mmol/L Tris (pH 9.5) for 5 minutes.
For neuraminidase digestion in situ, RBC ganglio-
sides were separated by HPTLC as before. PIBM-fixed
HPTLC plates were blocked with PBS-1 percent BSA for
15 minutes and then overlayed with Clostridium perfrin-
gens neuraminidase (type V, EC 3.2.1.18; Sigma Chemical
Co., 20 mU/mL in PBS-1 percent BSA) for 2 hours at 37∞C.
After digestion, plates were washed with PBS and then
subjected to HPTLC immunostaining with either MoAb
MC631 or MoAb FE-A5 as a control.32
Statistical analysis
Differences in HPTLC immunostaining results were com-
pared by the t test. Graphic and statistical analyses were
performed with computer software (KalidaGraph, Read-
ing, PA).
RESULTS
B2 specifically recognizes MSGG or LKE antigen
It has been suggested that MoAb B2 recognizes a develop-
mentally regulated, globo-GSL during embryonic adrenal
differentiation. To test the latter, we screened B2 against a
panel of GSL standards and total tissue GSLs. As shown in
Table 1 and Fig. 1A, MoAb B2 specifically recognized
MSGG or LKE antigen. The latter is a sialylated GSL or
ganglioside that shows restricted tissue expression.13,32
Although MoAb B2 recognized MSGG, B2 did not
cross-react with any globo-precursor (Gb3, Gb4, Gb5), sug-
gesting that B2 binding requires the presence of a terminal
sialic acid. In addition, MoAb B2 did not cross-react with
any ganglio-series GSLs, including GD1a. Like MSGG, the
latter possesses a terminal NeuAca2-3Galb1-3GalNAcb1-
R motif (Table 1). Two known anti-MSGG/LKE MoAbs,
MC813-70 and RM1,23,27 were tested in parallel with similar
results. Overall, these results suggest that MoAb B2
requires both a terminal sialic acid and a globo-oligosac-
charide core for recognition.
MoAb B2 recognizes a LKE-active ganglioside 
in RBC
MSGG is reportedly the LKE antigen on human RBCs.28,29
We therefore tested MoAb B2 against the total ganglioside
fraction of LKE-S RBCs (Fig. 1D, Lane 2). MoAb B2 recog-
nized a trace ganglioside in LKE-S RBC with the same
mobility as the MSGG standard (Fig. 1D, Lane 1, Rf 0.30).
A RBC ganglioside with similar mobility was also observed
after staining with MoAbs MC813-70 (Fig. 1E) and RM1
Fig. 1. MoAb recognizes a RBC ganglioside consistent with 
MSGG or LKE antigen. (A) MoAb B2 was tested against RBC-
neutral GSLs (Lane 1), CMH (Lane 2), CDH (Lane 3), Gb3 
(Lane 4), Gb4 (Lane 5), Forssman (Lane 6), linear B (Lane 7), Gb5 
(Lane 8), MSGG or LKE (Lane 9), GM4 (Lane 10), GM2 (Lane 11), 
GM3 (Lane 12), GD3 (Lane 13), brain gangliosides (Lane 14), and 
RBC gangliosides (Lane 15). A MoAb B2+ band was observed 
with MSGG and RBC gangliosides (Rf 0.30). (B) RBC (R) and 
brain (Br) gangliosides chemically stained with diphenylamine 
reagent. (C-G) MSGG standard (Lane 1) and total RBC ganglio-
sides (Lane 2) stained with diphenylamine (C), MoAbs B2 (D), 
MC813-70 (E), RM1 (F), and MC631 (G). GSL structures are 
shown in Table 1. Solvent, C-M-0.2 percent aqueous CaCl2 
(55:45:10, vol/vol/vol).
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(Fig. 1F). No B2 binding was observed to any GSL in the
neutral fraction of RBC (Fig. 1A, Lane 1). To confirm that
the B2+ band in RBC was MSGG-LKE, RBC gangliosides
were first digested with neuraminidase in situ to remove
the terminal sialic acid (Table 1) and then stained with
MoAb MC631, an anti-Gb5/Gb4 MoAb.23,32 As shown, a
MC631+ band was detected (Fig. 1G) with the same mobil-
ity as MSGG and MoAb B2.
B2 staining is dependent on LKE-phenotype
To determine whether B2 staining to RBC gangliosides
was dependent on LKE phenotype, MoAb B2 was tested
against a panel of RBC gangliosides isolated from LKE-N
(n = 2), LKE-W (n = 4), and LKE-S donors (n = 9). B2 bind-
ing was compared by scanning densitometry of HPTLC
plates (Fig. 2). MoAbs MC813-70 and RM1 were included
as controls, as before.
In the MC813-70 control (Fig. 2A), there was a clear
dose-response relationship between staining intensity
and LKE phenotype, which was significant (p < 0.001, t
test). MoAbs B2 and RM1 strongly stained LKE-S samples;
however, little or no staining was observed in LKE-W and
LKE-N samples. The inability of either MoAb B2 or RM1
to significantly bind LKE-W and LKE-N samples suggests
that these antibodies may require a minimum antigen
concentration and density to support antibody binding.
MSGG and B2 ganglioside have restricted tissue 
expression
MSGG-LKE expression is relatively restricted on human
tissues. To verify that the B2 antigen shares the same tissue
distribution and restriction as the LKE-MSGG antigen,
MoAbs B2 and MC813-70 were screened against the gan-
glioside fractions from RBC, lymphocytes, neutrophils,
monocytes, kidney, and brain. Consistent with the known
distribution of MSGG,5,23,32 MC813-70+
and B2+ gangliosides were observed
in RBCs and kidney. No bands were
observed in any other tissues tested.
MoAb B2 does not hemagglutinate 
human RBC
The ability of MoAbs B2, RM1, and
MC813-70 to agglutinate RBCs was
tested against either washed or ficin-
modified LKE-S RBC using standard
conditions established for MoAb
MC813-70.28,29 No MoAb tested was
capable of agglutinating washed RBCs.
As reported,29 MoAb MC813-70 strongly
agglutinated ficin-modified LKE-S RBC.
In contrast, neither MoAb B2 nor MoAb
RM1 agglutinated ficin-treated RBCs, even after pro-
longed 4∞C incubation (up to 4 hr), increasing the anti-
body-cell ratio and filter concentrating the antibody 50-
fold. Contrary to expectations, MoAb B2 is not a viable
serologic reagent for LKE phenotyping.
Differential reactivity of anti-MSGG-LKE MoAbs by 
flow cytometry
The reactivities of MoAbs B2, RM1, and MC813-70 were
also compared by flow cytometry (Fig. 3). All three MoAbs
were tested against ficin-treated LKE-S RBCs and two,
MSGG+ RCC lines, A498 and ACHN. MSGG-LKE is strongly
expressed in some RCCs, where it is hypothesized to play
a role in tumor growth and metastasis.35,36
As previously reported,28,29 strong MoAb MC813-70
binding was observed against LKE-S RBCs. Neither MoAb
B2 nor MoAb RM1 stained RBCs. Differential staining was
observed with the RCC lines. Although all three antibodies
strongly bound ACHN cells, only MC813-70 significantly
stained A498 cells. In A498 cells, B2 staining was decreased
50 percent and was essentially absent with MoAb RM1.
These differences are reminiscent of other anti-carbohy-
drate MoAbs, which may recognize the same epitope but
display different staining characteristics when tested
against intact cell membranes.27,37
DISCUSSION
MSGG or LKE antigen is a high-incidence antigen (98%-
99% of donors) on human RBCs.28,29 Because it is a
high-incidence RBC antigen, very few examples of human
anti-LKE are described in the literature.38-40 Like anti-Pk
and P antibodies, examples of human anti-LKE are typi-
cally of IgM isotype, showing enhanced reactivity at 4∞C
and after protease digestion.38 Although human anti-LKE
is not readily available, MoAb MC813-70, a murine MoAb
Fig. 2. MoAb B2 staining to RBC gangliosides is dependent on donor LKE phenotype. 
MoAbs MC813-70 (A), B2 (B), and RM1 (C) were tested against isolated RBC ganglio-
sides from LKE-N (N), LKE-W (W), and LKE-S (S) donors by HPTLC immunostaining. 
Staining was quantitated by scanning densitometry (area, mean ± SD).
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with anti-MSGG specificity,23 has been validated as an
anti-LKE serologic reagent.28,29,40 MoAb MC813-70 was
shown to have LKE specificity, failing to hemagglutinate p,
Pk, and LKE-N RBC controls.29 Unlike examples of human
anti-LKE, MoAb MC813-70 strictly requires prior enzyme
modification of RBC for binding. This difference may
reflect differences in antibody class between MoAb
MC813-70 (IgG4) and human anti-LKE (IgM). MoAb
MC813-70 also differs subtly from human anti-LKE in
large population studies. Examples of human anti-LKE
suggest an association between ABO and weak LKE
expression whereas no linkage disequilibrium is observed
with MoAb MC813-70.28,29,38
In this study, we evaluated two IgM, anti-MSGG
MoAbs B2 and RM1. RM1, raised against MSGG isolated
from metastatic RCC, has strict specificity for MSGG.27
Likewise, we have shown that B2, an antibody raised
against embryonic adrenal cells,20-22 also has anti-MSGG
activity. Both antibodies recognized MSGG present in the
RBC ganglioside fraction by HPTLC immunostaining;
however, neither antibody bound intact RBC membranes
by either flow cytometry or direct agglutination assays. In
contrast, both antibodies stained RCCs, suggesting that
these antibodies may require a higher antigen density
on cell membranes to support antibody binding. Unlike
human RBCs, in which LKE is a trace ganglioside (<1%-2%
total), MSGG is a major RCC ganglioside, constituting up
to 50 percent total ganglioside and 90 percent of the GSL
present in lipid-rafts.35,36
The identification of the B2 antigen
as MSGG-LKE suggests a possible role
for LKE in neural crest differentiation. It
is well established that neurons of the
sympathetic nervous system and adre-
nal chromaffin cells share a common
embryonic heritage via the caudal neu-
ral crest.20-22 A transient marker on bipo-
tential embryonic adrenal cells, LKE
or B2 antigen signals early neuroblast
commitment along sympathetic neural
development.21 In the spinal cord,
which also arises from the caudal neural
crest, LKE, and its precursor Gb5
(Table 1), specifically identify subsets of
myelinated afferent sensory neurons
responsible for transmitting proprio-
ception and touch.16-18 After synapsing
in the spinal cord dorsal horn, these
LKE+ neurons synapse with their corre-
sponding sensory ganglia in the cerebel-
lum. Like their dorsal horn
counterparts, these afferent sensory
ganglia cells are also LKE-positive.16,17
In summary, we have identified the
B2 antigen as the globo-ganglioside, MSGG, or LKE anti-
gen. Our findings suggest a potential role for MSGG in
neuroendocrine differentiation, marking immature sym-
pathetic neuroblasts and bipotential embryonic adrenal
chromaffin cells. Unfortunately, MoAb B2 is not useful as
a serologic reagent for RBC phenotyping. MoAb B2 may,
however, be a useful reagent for embryonic stem cells,4,5
embryonic carcinoma cells, and RCCs,6,13,35,36 which
strongly express MSGG or LKE antigen.
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